Researcher.Life Logo

Endocrine, Metabolic and Immune Disorders - Drug Targets : Impact Factor & More

eISSN: 2212-3873pISSN: 1871-5303

Key Metrics

CiteScore
3.8
Impact Factor
< 5
SNIP
0.7
Recommended pre-submission checks
Powered by Paperpal by Editage

Endocrine, Metabolic and Immune Disorders - Drug Targets Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Endocrine, Metabolic and Immune Disorders - Drug Targets ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endocrine, Metabolic and Immune Disorders - Drug Targets

Evaluation of the Effectiveness of Hyodine on Healing of Diabetic Foot Ulcer: A Randomized Single-Blind Controlled Trial.
  • 7 May 2026
  • Endocrine, metabolic & immune disorders drug targets
Integrated Analysis of Immune-Related Genes Reveals Altered Biological Functions and Immune Cell Abundance in Sleep Deprivation.
  • 7 May 2026
  • Endocrine, metabolic & immune disorders drug targets
Paricalcitol Attenuates Bleomycin-induced Pulmonary Fibrosis: Insights from Immunohistochemical and Molecular Genetic Analysis
  • 30 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Genetically Predicted 12,13-DiHOME Mediates the Association between TNF-Related ApoptosisInducing Ligand and Immune Thrombocytopenia
  • 30 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Intervention Strategies using Agada (Ayurvedic Antitoxic Formulations) for Diseases caused by Endocrine Disruptors
  • 30 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Impact of Clinical Factors on Bone Microarchitecture in Patients with Turner Syndrome
  • 29 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Evaluation of the Effectiveness of Hyodine on Healing of Diabetic Foot Ulcer: A Randomized Single-Blind Controlled Trial.
  • 7 May 2026
  • Endocrine, metabolic & immune disorders drug targets
Integrated Analysis of Immune-Related Genes Reveals Altered Biological Functions and Immune Cell Abundance in Sleep Deprivation.
  • 7 May 2026
  • Endocrine, metabolic & immune disorders drug targets
Paricalcitol Attenuates Bleomycin-induced Pulmonary Fibrosis: Insights from Immunohistochemical and Molecular Genetic Analysis
  • 30 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Genetically Predicted 12,13-DiHOME Mediates the Association between TNF-Related ApoptosisInducing Ligand and Immune Thrombocytopenia
  • 30 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Intervention Strategies using Agada (Ayurvedic Antitoxic Formulations) for Diseases caused by Endocrine Disruptors
  • 30 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets
Impact of Clinical Factors on Bone Microarchitecture in Patients with Turner Syndrome
  • 29 Apr 2026
  • Endocrine, Metabolic &amp; Immune Disorders - Drug Targets

FAQs on Endocrine, Metabolic and Immune Disorders - Drug Targets